Osivelotor clinical trials
Also written GBT021601 and PF-07940367.
How each study uses osivelotor is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the osivelotor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test osivelotor.
Studies
Open first, then newest update. How each study uses osivelotor is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy AdultsRecruitingPhase 1PfizerNCT06507904Written as Osivelotor
- A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCDRecruitingPhase 2/3PfizerNCT05431088Written as Osivelotor
- GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD)TerminatedPhase 2/3PfizerNCT05632354Written as Osivelotor
- A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver FunctionCompletedPhase 1PfizerNCT06340347Written as Osivelotor
- A GBT021601 ADME Microtracer Study in Healthy VolunteersCompletedPhase 1PfizerNCT05718687Written as GBT021601
- Study of GBT021601 in Participants With Renal ImpairmentTerminatedPhase 1PfizerNCT05878704Written as GBT021601
- A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy AdultsCompletedPhase 1PfizerNCT06190561Written as PF-07940367
- A Study to Evaluate GBT021601-012 Single Dose and Multiple Dose in Participants With Sickle Cell Disease (SCD)CompletedPhase 1PfizerNCT04983264Written as GBT021601
- A Study to Evaluate GBT021601 in Single and Multiple Doses in Healthy ParticipantsCompletedPhase 1PfizerNCT05036512Written as GBT021601
Codes
What other systems call osivelotor · ClinicalTrials.gg INT018136
- UNII (FDA) UK749B4S16OSIVELOTORConfirmed FDA, Wikidata
- Wikidata Q136305822osivelotorConfirmed FDA, Wikidata
- NCI Thesaurus C199086OsivelotorOne source FDA
- DrugBank DB18071One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | UK749B4S16 | OSIVELOTOR | Confirmed FDA, Wikidata |
| Wikidata | Q136305822 | osivelotor | Confirmed FDA, Wikidata |
| NCI Thesaurus | C199086 | Osivelotor | One source FDA |
| DrugBank | DB18071 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.